A detailed history of Graham Capital Management, L.P. transactions in Catalent, Inc. stock. As of the latest transaction made, Graham Capital Management, L.P. holds 8,512 shares of CTLT stock, worth $510,039. This represents 0.02% of its overall portfolio holdings.

Number of Shares
8,512
Holding current value
$510,039
% of portfolio
0.02%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$53.58 - $57.02 $456,072 - $485,354
8,512 New
8,512 $478,000
Q4 2023

Feb 14, 2024

BUY
$32.18 - $46.57 $452,322 - $654,587
14,056 New
14,056 $631,000
Q3 2022

Nov 14, 2022

SELL
$72.36 - $113.1 $397,545 - $621,371
-5,494 Reduced 47.99%
5,955 $430,000
Q2 2022

Aug 15, 2022

BUY
$87.2 - $114.05 $998,352 - $1.31 Million
11,449 New
11,449 $1.23 Million
Q1 2022

May 16, 2022

SELL
$94.19 - $124.49 $403,980 - $533,937
-4,289 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$119.57 - $139.07 $512,835 - $596,471
4,289 New
4,289 $549,000

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $10.8B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Graham Capital Management, L.P. Portfolio

Follow Graham Capital Management, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Graham Capital Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Graham Capital Management, L.P. with notifications on news.